Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

University Hospital Salzburg Selects IntraOp® Mobetron®

SUNNYVALE, Calif., September 17, 2019 /PRNewswire-PRWeb/ -- IntraOp Medical Corporation announced today that University Hospital Salzburg (SALK) Austria has purchased the IntraOp's third generation Mobetron and advanced treatment planning software, to pursue implementing Image Guided Electron Therapy (IGET) for intraoperative radiation therapy (IORT) clinically.

The Paracelsus Medical University Hospital Salzburg has been a pioneering thought leader in IORT for more than 20 years. Professor Felix Sedlmayer, head of radiation oncology and president of the International Society of IORT (ISIORT) said: "We consider Mobetron as a perfect platform for further development of our IORT program and to implement image guided 3D treatment planning."

Prof. Sedlmayer is the Principal Investigator in the ongoing HIOB trial (Hypofractionated Whole-Breast Irradiation preceded by Intra-Operative Radiotherapy with Electrons as anticipated Boost). HIOB is the largest prospective multi-institutional trial studying the benefits of electron IORT in the treatment of breast cancer.

"We are delighted to be partnering with Professor Sedlmayer and the team at University Hospital Salzburg and providing the most advanced IORT technology available today," said Derek T. DeScioli, Chief Executive Officer of IntraOp Medical Corporation. "Their institution has been a pioneer in IORT from the beginning, and we look forward to working with them to advance the research and technology to the next level of sophistication."

IntraOp will be providing to University Hospital Salzburg its third generation Mobetron technology including automatic soft docking, Prelude® IORT Management system and Radiance® 3D treatment planning as well high density radiotranslucent applicators compatible with Image Guided Electron Therapy.

About IntraOp Medical Corporation
IntraOp® is the leading innovator of electron radiation devices for treating cancer as an adjunct to invasive surgical procedures. As the developer and manufacturer of Mobetron®, IntraOp pioneered the world's first portable, self-shielded LINAC used for electron-based Intraoperative Radiation Therapy (IORT). Over 20,000 patients in 16 countries have benefited from Mobetron IORT. Based in Sunnyvale, California, IntraOp is a cancer care company uniting radiation and surgical oncology in the fight against cancer. For more information, please visit https://intraop.com.

Product photography available upon request.


SOURCE IntraOp Medical Corporation

These press releases may also interest you

at 02:05
At the 20th edition of the Deloitte Technology Fast50 award ceremony, PastBook (https://www.pastbook.com) - the global platform for one click photo products, based in Amsterdam and founded by Italian entrepreneur Stefano Cutello - won the category...

at 02:05
World Wide Technology (WWT), a market-leading, $11 billion technology solution provider, today announced the availability of its first end-to-end Virtual Central Office (VCO) solution. Developed in WWT's Advanced Technology Center (ATC), the WWT VCO...

at 02:00
ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company, today announced the signing of a multi-party collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN), Pfizer Inc. and Takeda Pharmaceutical Company Limited (Takeda)...

at 02:00
Yourway, the only truly integrated premium courier and clinical packager in the industry, announced its establishment of a new location within the European Union providing storage and distribution services, including secondary packaging capabilities,...

at 02:00
By 2030, Germany could produce at least five digital giants?like Amazon in US retail or Tencent in Chinese media?in massive markets such as: food, retail, automotive, logistics and appliances because of world-class incumbents including: Aldi, BMW,...

at 01:05
Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and precision medicine, today announced a collaboration agreement with RadioMedix Inc., a radiopharmaceutical company, to...

News published on 17 september 2019 at 00:00 and distributed by: